Lacosamide in paroxysmal kinesigenic dyskinesia

Movement Disorders

Volumn 27, Issue 6, 2012, Pages 801-802

  Mathew, Thomas ^a   Aroor, Sushanth ^a   Nadig, Raghunandan ^a   Sarma, G R K ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HARKOSERIDE; OXCARBAZEPINE; TOPIRAMATE;

ADULT; AMNESIA; CASE REPORT; CROSS ALLERGY; DRUG SAFETY; DRUG WITHDRAWAL; DYSKINESIA; FALLING; FOLLOW UP; HUMAN; LETTER; MALE; NERVE CELL PLASTICITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PAROXYSMAL KINESIGENIC DYSKINESIA; PRIORITY JOURNAL; SPEECH DISORDER; TREATMENT RESPONSE;

ACETAMIDES; ANTICONVULSANTS; DYSKINESIAS; HUMANS; MALE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84861682983     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.24928     Document Type: Letter

References (4)

1. Bhatia KP. Paroxysmal dyskinesias. Mov Disord. 2011; 26: 1157-1165.
2. Margari L, Presicci A, Ventura P, Margari F, Perniola T. Channelopathy: hypothesis of a common pathophysiologic mechanism in different forms of paroxysmal dyskinesia. Pediatr Neurol. 2005; 32: 229-235.
3. Unterberger I, Trinka E. Diagnosis and treatment of paroxysmal dyskinesia revisited. Ther Adv Neurol Disord. 2008; 1: 4-11.
4. Beyreuther BK, Freitag J, Heers C, Krebsfänger N, Scharfenecker U, Stöhr T. Lacosamide: a review of preclinical properties. CNS Drug Rev. 2007; 13: 21-42.